ArticleBMC anesthesiology2025
The association between neostigmine and postoperative atelectasis in elderly patients undergoing laparoscopic pancreaticoduodenectomy: a retrospective single-center propensity score matched study.
Article in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundIt is uncertain whether neostigmine reversal improves postoperative pulmonary outcomes. This study aimed to evaluate the association between neostigmine and postoperative atelectasis, and other complications in elderly patients undergoing laparoscopic pancreaticoduodenectomy (LPD).
methodsThis single-center retrospective cohort study included elderly patients who underwent LPD between 2019 and 2022, using cis-atracurium as the sole neuromuscular blocking agent. Participants were divided into two groups based on exposure to neostigmine: the neostigmine reversal group (exposed) and the control group (not exposed). The primary endpoint was the incidence of atelectasis within the first 3 postoperative days. Secondary endpoints included the incidence of pneumonia, pleural effusion, acute respiratory distress syndrome (ARDS), time to extubation, length of stay in the post-anesthesia care unit (PACU) and hospital, reintubation, postoperative blood gas analysis, 30-day readmission, and 30-day mortality. Propensity score matching (PSM) was performed based on baseline and intraoperative characteristics to minimize potential bias.
resultsOf the 501 patients initially included, 302 were successfully matched after PSM at a 1:5 ratio, comprising 89 patients in the neostigmine reversal group and 213 in the control group. Compared to the control group, the incidence of postoperative atelectasis was lower in the neostigmine reversal group (OR 0.43 [95% CI 0.24-0.75], p = 0.003) in elderly patients undergoing elective LPD. For secondary outcomes, time to extubation (Median [IQR] 20.00 [10.00-32.50] min vs. 25.00 [15.00-41.00] min, p < 0.001), and the length of stay in the PACU (Median [IQR] 55.00 [45.00-67.50] min vs. 60.00 [50.00-84.00] min, p = 0.013) were shortened, and the oxygen index (OI) at 2 h after extubation was increased (Median [IQR] 339.00 (275.76-453.03) vs. 310.00 (262.31-378.00), p < 0.001) in the neostigmine reversal group. Binomial logistic regression showed that age (OR 1.08 [95% CI 1.04-1.12], p < 0.001), neostigmine reversal (OR 0.43 [95% CI 0.24-0.76], p = 0.004), and intraoperative total fluid infusion (OR1.00 [95% CI 1.000-1.001], p = 0.009) were significantly associated with atelectasis after LPD.
conclusionsIn this single-center PSM study, neostigmine reversal was associated with lower incidence of atelectasis within the first 3 postoperative days, shorter time to extubation, shorter length of stay in the PACU, and increased OI at 2 h after extubation in elderly patients undergoing elective LPD. Postoperative atelectasis was associated with older age, greater intraoperative total fluid infusion, and the absence of neostigmine reversal. These results should be interpreted as hypothesis-generating, and warrant validation through randomized controlled trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.